NCT00006104 - Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions

Breast Cancer

Interventions

BIOLOGICAL

trastuzumab

DRUG

docetaxel

Trial Locations (15)

19111

Fox Chase Cancer Center, Philadelphia

36608

Providence Hospital, Mobile

37067

Williamson Medical Center, Franklin

37205

St. Thomas Health Services, Nashville

37403

Erlanger Health Systems, Chattanooga

37404

Memorial Health Care System, Chattanooga

37831

Methodist Medical Center of Oak Ridge, Oak Ridge

37916

Methodist/Thompson Oncology Research, Knoxville

37920

Tennessee Cancer Specialists, Knoxville

38104

Boston Baskin Cancer Group, Memphis

38301

Jackson-Madison County Hospital, Jackson

42303

Owensboro Medical Health System, Owensboro

60201

Evanston Hospital, Evanston

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt-Ingram Cancer Center

OTHER